AzTrials
AzTrials

Blood Flow Restriction TrainingNCT06976281

Effect of Intradialytic Blood Flow Restriction Training on Functional Capacity, Estimated Glomerular Filtration Rate and Health Related Quality of Life in Patients on Hemodialysis

A study testing conventional exercise Program and blood flow restriction training in people with Blood Flow Restriction Training and Glomerular Filtration Rate, run by Beni-Suef University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

this study was done to investigate the effect of intradialytic blood flow restriction training on functional capacity, estimated glomerular filtration rate and health related Quality of life in patients on Hemodialysis Read more about this study

Who is it for?
Ages 40 to 60 years
What is being tested?
conventional exercise Program and blood flow restriction training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteEgypt
Study dates
1 Aug 2024to 15 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • All patients were
  • Both sex aged from forty to sixty years
  • Stable chronic hemodialysis patient (< 3 months)
  • Participants will be deemed medically eligible by their treating physician before participation in the present study
  • Free from any other disease could interfere with exercise

Who cannot join

  • Hemodynamic instability during hemodialysis over the last month
  • Neurodegenerative diseases
  • Autoimmune diseases (i.e., lupus erythematosus)
  • Surgery within the past 3 months
  • Severe arrhythmia, angina or cerebrovascular disease
  • Unstable on dialysis
  • Any musculoskeletal problem interfere with exercise

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • out-patient clinic, faculty of physical therapy, beni-suef University

    Banī Suwayf

Other trials in Egypt

About this study

this study was done to investigate the effect of intradialytic blood flow restriction training on functional capacity, estimated glomerular filtration rate and health related Quality of life in patients on Hemodialysis

Read the detailed description

Chronic kidney disease affects 10% to 15% of the population and is characterized by a progressive decline in glomerular filtration rate. The disease can lead to frailty, muscle mass wasting, and sarcopenia, affecting functional mobility and quality-of-life measures. The increased protein catabolism in Chronic kidney disease is partly due to inflammatory status, nutrient loss during dialysis, and musculoskeletal system changes. Assessment of muscle functionality can provide additional diagnostic and prognostic information for clinical outcomes, quality of life, and mortality rates. Exercise training with blood flow restriction is a potential method for clinical musculoskeletal rehabilitation, potentially improving strength, physical function, blood pressure control, glucose homeostasis, autonomic function, renal deterioration, dialysis adequacy, and antioxidant defenses.

Being tested
conventional exercise Program, blood flow restriction training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • conventional exercise ProgramOther

    Exercises include shoulder flexion, shoulder abduction, leg extension, and hand grip. Start with 1-3 sets of 12 reps at 30% of 1-repetition maximum, increasing by 10% according to patient endurance. Cycling is a 30-minute chair or bedside cycle ergometer exercise 2 time/weak for 2 consecutive months

  • blood flow restriction trainingOther

    Patients received the same conventional exercise program, which included isometric, aerobic, and resisted exercise individualized for every patient with blood flow restriction by 50% of limb occlusion pressure. Training will be conducted for 2 time/weak for 2 consecutive month

Study groups in NCT06976281
Study groupRoleWhat they receive
blood flow restrictionExperimentalIncluded 15 chronic kidney disease patients on hemodialysis received conventional exercise program included isometric, aerobic, and resisted exercise individualized for every patient with blood flow restriction by 50% of limb occlusion Pressure. training was conducted for 2 time/weak for 2 consecutive month
Receives: Other: conventional exercise Program; Other: blood flow restriction training
conventional exercise ProgramActive comparatorIncluded 15 chronic kidney disease patients on hemodialysis received conventional exercise program only included isometric, aerobic, and resisted exercise individualized for every patient. training was conducted for 2 time/weak for 2 consecutive month
Receives: Other: conventional exercise Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. assessment of change of estimated glomerular filtration rate

    Estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration Creatinine Equation (2021) as recommended by the National Kidney Foundation to assess renal function and detect deterioration.

    Measured: at baseline and after 8 weeks

Secondary outcomes (4)
  1. assessment of change of Limb Occlusion Pressure

    Limb occlusion pressure was measured using a vascular Doppler ultrasound in combination with a blood flow restriction device to determine individualized occlusion thresholds.

    Measured: at baseline and after 8 weeks

  2. assessment of change of Glucose Homeostasis

    Glucose regulation was assessed through glycated hemoglobin (HbA1c) levels, reflecting average blood glucose over the previous 2-3 months

    Measured: at baseline and after 8 weeks

  3. assessment of change of upper limb Muscle Strength

    Upper limb strength was measured using a handgrip dynamometer.

    Measured: at baseline and after 8 weeks

  4. assessment of change of lower limb Muscle Strength

    lower limb strength was assessed using the One-Repetition Maximum (1RM) test to determine maximum voluntary strength

    Measured: at baseline and after 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 May 2025
  2. Study start1 Aug 2024
  3. Primary completion15 Nov 2024
  4. Study completion15 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06976281
Sponsor's protocol ID
Alaa-02012024
Status last verified
May 2025
First submitted
9 May 2025
Last updated
16 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing conventional exercise Program and blood flow restriction training in people with Blood Flow Restriction Training and Glomerular Filtration Rate, run by Beni-Suef University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

assessment of change of estimated glomerular filtration rate (time frame: at baseline and after 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in